|
BCL11A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66622271535743E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40130026973873E-10 |
| Normal-vs-Stage2 |
1.110010E-02 |
| Normal-vs-Stage3 |
9.60629999999796E-05 |
| Normal-vs-Stage4 |
8.224500E-03 |
| Stage1-vs-Stage2 |
7.262600E-01 |
| Stage1-vs-Stage3 |
6.852400E-01 |
| Stage1-vs-Stage4 |
8.501600E-01 |
| Stage2-vs-Stage3 |
5.609200E-01 |
| Stage2-vs-Stage4 |
6.976400E-01 |
| Stage3-vs-Stage4 |
9.416200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67066360745594E-12 |
| Normal-vs-AfricanAmerican |
1.36100000047712E-07 |
| Normal-vs-Asian |
5.394600E-01 |
| Caucasian-vs-AfricanAmerican |
6.051600E-01 |
| Caucasian-vs-Asian |
1.247610E-01 |
| AfricanAmerican-vs-Asian |
1.541440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93431945408429E-13 |
| Normal-vs-Female |
5.57510000387396E-08 |
| Male-vs-Female |
4.605400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.53229999980631E-07 |
| Normal-vs-Extreme_Weight |
1.14399999473491E-08 |
| Normal-vs-Obese |
3.4023999950783E-08 |
| Normal-vs-Extreme_Obese |
1.201810E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.780800E-01 |
| Normal_Weight-vs-Obese |
9.114400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.294800E-01 |
| Extreme_Weight-vs-Obese |
4.668200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.799200E-01 |
| Obese-vs-Extreme_Obese |
9.838000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.723890E-02 |
| Normal-vs-Age(41-60Yrs) |
1.31561428418081E-12 |
| Normal-vs-Age(61-80Yrs) |
2.61149990521403E-11 |
| Normal-vs-Age(81-100Yrs) |
1.978380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.717790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.157400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.470200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.789600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.535800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.932800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.143900E-03 |
| Normal-VS-KIRP CIMP |
6.984000E-02 |
| Normal-VS-Unclassified PRCC |
3.178700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.07370000007801E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.867600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.802400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.856800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.523600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.365800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.09949999999881E-05 |
| Normal-vs-N1 |
1.550480E-04 |
| Normal-vs-N2 |
5.882000E-01 |
| N0-vs-N1 |
6.466100E-02 |
| N0-vs-N2 |
4.749200E-01 |
| N1-vs-N2 |
1.956980E-01 |
|
|
